Evidence map›Paper›PMID 37555834›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2023

Analysis of reproducibility and robustness of a renal proximal tubule microphysiological system OrganoPlate 3-lane 40 for in vitro studies of drug transport and toxicity.

Courtney Sakolish, Haley L Moyer, Han-Hsuan D Tsai, Lucie C Ford, Allison N Dickey, Fred A Wright, Gang Han, Piyush Bajaj, Maria T Baltazar, Paul L Carmichael and 3 more

Open access · greenAbstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Advances in Cytotoxicity Testing: From In Vitro Assays to In Silico Models.International journal of molecular sciences · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Courtney SakolishDepartment of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Texas 77843, USA.
Haley L MoyerDepartment of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Texas 77843, USA.
Han-Hsuan D TsaiDepartment of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Texas 77843, USA.ORCID 0000-0002-3484-5955
Lucie C FordDepartment of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Texas 77843, USA.
Allison N DickeyBioinformatics Research Center, North Carolina State University, Raleigh, North Carolina 27695, USA.
Fred A WrightBioinformatics Research Center, North Carolina State University, Raleigh, North Carolina 27695, USA.
Gang HanDepartment of Epidemiology and Biostatistics, Texas A&M University, College Station, Texas 77843, USA.
Piyush BajajGlobal Investigative Toxicology, Preclinical Safety, Sanofi, Cambridge, Massachusetts 02141, USA.
Maria T BaltazarSafety & Environmental Assurance Centre (SEAC), Unilever, Bedfordshire MK44 1LQ, UK.
Paul L CarmichaelSafety & Environmental Assurance Centre (SEAC), Unilever, Bedfordshire MK44 1LQ, UK.
Jason P StankoDivision of Translational Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, USA.
Stephen S FergusonDivision of Translational Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, USA.ORCID 0000-0003-3172-8347
Ivan RusynDepartment of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Texas 77843, USA.
Texas A&M University · USNational Institute of Environmental Health Sciences · USNorth Carolina State University · USUnilever (United Kingdom) · GBSanofi (United States) · US

Funding

Single cell, multi-parametric high throughput platform to classify endocrine disruptor potential of mixturesP42ES027704 · NIEHS · TEXAS A&M UNIVERSITY · PI Efstratios Pistikopoulos · 2017 to 2026
$21.2M
Safe and Sustainable Alternatives Research ProgramZIAES103381 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI FERGUSON, STEPHEN · 2022 to 2025
$7.0M
TEX-VAL: Texas A&M Tissue Chip Validation CenterU24TR001950 · NCATS · TEXAS A&M UNIVERSITY · PI RUSYN, IVAN · 2016 to 2017
$4.2M
Regulatory Science in Environmental Health and ToxicologyT32ES026568 · NIEHS · TEXAS A&M UNIVERSITY · PI Weihsueh A Chiu, Natalie M Johnson · 2016 to 2026
$3.8M
TEX-VAL: Texas A&M Tissue Chip Validation ConsortiumU24TR002633 · NCATS · TEXAS A&M UNIVERSITY · PI RUSYN, IVAN, STEPHAN, CLIFFORD C · 2018 to 2019
$3.0M
IMSD at Texas A&M University: Initiative for Maximizing Student Diversity in Biomedical SciencesT32GM135748 · NIGMS · TEXAS A&M UNIVERSITY · PI BRINKMEYER-LANGFORD, CANDICE L., CHIU, WEIHSUEH A · 2020 to 2024
$1.2M
NCATS NIH HHS U24 TR001950NCATS NIH HHS U24 TR002633NIEHS NIH HHS P42 ES027704NIEHS NIH HHS T32 ES026568
6 · The paper itself

Abstract

Microphysiological systems are an emerging area of in vitro drug development, and their independent evaluation is important for wide adoption and use. The primary goal of this study was to test reproducibility and robustness of a renal proximal tubule microphysiological system, OrganoPlate 3-lane 40, as an in vitro model for drug transport and toxicity studies. This microfluidic model was compared with static multiwell cultures and tested using several human renal proximal tubule epithelial cell (RPTEC) types. The model was characterized in terms of the functional transport for various tubule-specific proteins, epithelial permeability of small molecules (cisplatin, tenofovir, and perfluorooctanoic acid) versus large molecules (fluorescent dextrans, 60-150 kDa), and gene expression response to a nephrotoxic xenobiotic. The advantages offered by OrganoPlate 3-lane 40 as compared with multiwell cultures are the presence of media flow, albeit intermittent, and increased throughput compared with other microfluidic models. However, OrganoPlate 3-lane 40 model appeared to offer only limited (eg, MRP-mediated transport) advantages in terms of either gene expression or functional transport when compared with the multiwell plate culture conditions. Although OrganoPlate 3-lane 40 can be used to study cellular uptake and direct toxic effects of small molecules, it may have limited utility for drug transport studies. Overall, this study offers refined experimental protocols and comprehensive comparative data on the function of RPETCs in traditional multiwell culture and microfluidic OrganoPlate 3-lane 40, information that will be invaluable for the prospective end-users of in vitro models of the human proximal tubule.

Indexed as

Kidney Tubules, ProximalMicrophysiological SystemsHumansKidneyProspective StudiesReproducibility of Resultsin vitro modelskidneyvalidation

Identifiers

PMID37555834
PMCPMC10613961
OpenAlexW4385684390

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.